http://rdf.ncbi.nlm.nih.gov/pubchem/patent/TW-I263508-B
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_73d9d6b8eab2b38d95feb27531aef324 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate | 2004-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2006-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0c9fc7058f20efc4b2fe8823bab3769f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6d5673421bdde2d89ee788e5d64d54e |
| publicationDate | 2006-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | TW-I263508-B |
| titleOfInvention | Composition for a modified-release oral tablet and method for manufacturing of the composition |
| abstract | The present invention relates to a composition for a modified-release oral tablet, characterized in that comprising: a micronized active ingredient for lowering the blood glucose level and a modified-release agent for controlling the release of the active ingredient, and a method for manufacturing of the composition. |
| priorityDate | 2004-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 115.